srch

01.01.2022 · Temporal Muscle Thickness as a Prognostic Marker in Patients with Newly Diagnosed Glioblastoma: Translational Imaging Analysis of the CENTRIC EORTC 26071–22072 and CORE Trials

01.02.2022 · Circulating Tumor DNA in Stage III Colorectal Cancer, beyond Minimal Residual Disease Detection, toward Assessment of Adjuvant Therapy Efficacy and Clinical Behavior of …

Journal of Experimental & Clinical Cancer Research is an online peer-reviewed journal that provides a high-quality forum for all aspects of basic, clinical ...

Announcing our new Impact Factor: 12.531!

04.01.2022 · Purpose: Early diagnosis of cancer is critical for improving patient outcomes, but cancers may be hard to diagnose if patients present with nonspecific signs and symptoms. We have previously shown that nuclear magnetic resonance (NMR) metabolomics analysis can detect cancer in animal models and distinguish between differing metastatic disease burdens.

Clinical Cancer Research is a peer-reviewed medical journal on oncology, including the cellular and molecular characterization, prevention, diagnosis, ...

Clinical Cancer Research prioritizes the mechanistic evaluation of novel compounds and rational combinations for cancer therapy. Due to the overwhelming number of submissions in this Section of the Journal, guidelines are listed below to assist authors in their preparation of the manuscript.

15.01.2022 · Home | Clinical Cancer Research. The AACR remains fully committed to supporting publishing operations throughout this challenging time, while still remaining flexible and supportive of the author, reviewer, and editor communities that we serve. If you have any questions or concerns, please reach out to a member of the AACR publishing staff.

Clinical Cancer Research publishes innovative clinical and translational cancer research studies that bridge the laboratory and the clinic. The Journal is especially interested in clinical trials evaluating new treatments, accompanied by research on pharmacology, and molecular alterations or biomarkers that predict response or resistance to ...

12 rader · Journal Abbreviation: CLIN CANCER RES Journal ISSN: 1078-0432. About Clinical …

01.01.1995 · Search for this keyword . Advanced Search. Archive of all online content

Journal of Experimental & Clinical Cancer Research is an online peer-reviewed journal that provides a high-quality forum for all aspects of basic, clinical and translational work in oncology. Please click here to read more. Editor-in-Chief Mauro Castelli, Regina Elena National Cancer Institute, Italy

The "Journal of Cancer Research and Clinical Oncology" publishes significant and up-to-date articles within the fields of experimental and clinical oncology ...

Journal updates. The "Journal of Cancer Research and Clinical Oncology" publishes significant and up-to-date articles within the fields of experimental and clinical oncology. The journal, which is chiefly devoted to Original papers, also includes Reviews as well as Editorials and Guest editorials on current, controversial topics.

28.01.2022 · Park E-K, Thomas PS, Johnson AR, Yates DH. Osteopontin Levels in an Asbestos Exposed Population. (January 27, 2009) Clin Cancer Res, 10.1158/1078-0432.CCR-08-0360. Sign up to be notified each time OnlineFirst articles are posted in Clinical Cancer Research.

Announcing our new Impact Factor: 12.701! ... Current issue of Cancer Research ... Cancer Res January 15 2022 82 (2) 278-291; DOI:10.1158/0008-5472.

Jan 15, 2022 · Home | Clinical Cancer Research The AACR remains fully committed to supporting publishing operations throughout this challenging time, while still remaining flexible and supportive of the author, reviewer, and editor communities that we serve. If you have any questions or concerns, please reach out to a member of the AACR publishing staff.

Clinical Cancer Research, is a journal of the American Association for Cancer Research whose focus is to publish innovative clinical and translational cancer research studies that bridge the laboratory and the clinic.

15.01.2022 · A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART, SWOG S1609)

Clinical Cancer Research publishes innovative clinical and translational cancer research studies that bridge the laboratory and the clinic. The Journal is ...